NCT03851042

Brief Summary

Patients will be randomized to either receive virtual reality headsets in the post anesthesia recovery unit (PACU) as an adjunct therapy or undergo routine postoperative management. Pain scores will be recorded at standardized intervals in the PACU. The patient will be asked to complete a survey at their two week post op visit assessing their satisfaction with their post op recovery. The purpose of this study is to determine whether a virtual reality relaxation program used in the immediate postoperative period after laparoscopic hysterectomy will decrease pain scores and reduce both oral and intravenous opioid consumption.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 20, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 22, 2019

Completed
1.5 years until next milestone

Study Start

First participant enrolled

September 1, 2020

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 19, 2021

Completed
1.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2023

Completed
Last Updated

September 21, 2021

Status Verified

September 1, 2021

Enrollment Period

1 year

First QC Date

February 20, 2019

Last Update Submit

September 19, 2021

Conditions

Outcome Measures

Primary Outcomes (3)

  • PACU satisfaction survey

    Survey asking questions regarding their satisfaction with use of VR. A 7-point Likert scale will be used to assess satisfaction with VR modality. 1- very dissatisfied, 2-disatisfied, 3-neutral, 4-satisfied, 5-very satisfied

    2 weeks post operative visit

  • Meds used at home post op for pain control

    Patients will be asked about specific medications used at home for post op pain control. We will specifically determine the morphine equivalents used for opioids.

    2 week postoperative op visit

  • Visual Analogue scale for pain

    This is a 1-10 scale that will be asked to patients to assess pain level while in the postoperative care unit, 0=no pain on a graduated scale to 10=worst pain.

    Immediately following surgery

Study Arms (2)

Virtual Reality Head set in PACU

EXPERIMENTAL

Use of VR Headset in PACU post hysterectomy for up to 4 hours.

Device: Virtual Reality Head set in PACU

No intervention

ACTIVE COMPARATOR

Routine PACU care post hysterectomy for up to 4 hours

Other: No intervention

Interventions

Use of VR headset to determine post op satisfaction in PACU, decreased pain reduction and opioid consumption

Virtual Reality Head set in PACU

Routine post laparoscopic hysterectomy management (no VR headset)

No intervention

Eligibility Criteria

Age18 Years - 70 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Any patient undergoing laparoscopic hysterectomy
  • Benign indications
  • Dr. Jamal Mourad or Dr. Nichole Mahnert will be performing hysterectomy

You may not qualify if:

  • Non-English speakers
  • History of chronic opioid use
  • History of epilepsy
  • History of claustrophobia
  • Have received a prescription or taken opioids within 2 weeks for their scheduled surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Banner University Medical Center Phoenix

Phoenix, Arizona, 85006, United States

RECRUITING

Related Publications (7)

  • CDC Opioid Overdose. (August 30, 2017). Retrieved from https://www.cdc.gov/drugoverdose/epidemic/index.html

    BACKGROUND
  • Alam A, Gomes T, Zheng H, Mamdani MM, Juurlink DN, Bell CM. Long-term analgesic use after low-risk surgery: a retrospective cohort study. Arch Intern Med. 2012 Mar 12;172(5):425-30. doi: 10.1001/archinternmed.2011.1827.

    PMID: 22412106BACKGROUND
  • Nelson G, Altman AD, Nick A, Meyer LA, Ramirez PT, Achtari C, Antrobus J, Huang J, Scott M, Wijk L, Acheson N, Ljungqvist O, Dowdy SC. Guidelines for postoperative care in gynecologic/oncology surgery: Enhanced Recovery After Surgery (ERAS(R)) Society recommendations--Part II. Gynecol Oncol. 2016 Feb;140(2):323-32. doi: 10.1016/j.ygyno.2015.12.019. Epub 2016 Jan 3. No abstract available.

    PMID: 26757238BACKGROUND
  • Aman MM, Jason Yong R, Kaye AD, Urman RD. Evidence-Based Non-Pharmacological Therapies for Fibromyalgia. Curr Pain Headache Rep. 2018 Apr 4;22(5):33. doi: 10.1007/s11916-018-0688-2.

    PMID: 29619620BACKGROUND
  • Triscari MT, Faraci P, Catalisano D, D'Angelo V, Urso V. Effectiveness of cognitive behavioral therapy integrated with systematic desensitization, cognitive behavioral therapy combined with eye movement desensitization and reprocessing therapy, and cognitive behavioral therapy combined with virtual reality exposure therapy methods in the treatment of flight anxiety: a randomized trial. Neuropsychiatr Dis Treat. 2015 Oct 7;11:2591-8. doi: 10.2147/NDT.S93401. eCollection 2015.

    PMID: 26504391BACKGROUND
  • Yiannakopoulou E, Nikiteas N, Perrea D, Tsigris C. Virtual reality simulators and training in laparoscopic surgery. Int J Surg. 2015 Jan;13:60-64. doi: 10.1016/j.ijsu.2014.11.014. Epub 2014 Nov 18.

    PMID: 25463761BACKGROUND
  • Schmitt YS, Hoffman HG, Blough DK, Patterson DR, Jensen MP, Soltani M, Carrougher GJ, Nakamura D, Sharar SR. A randomized, controlled trial of immersive virtual reality analgesia, during physical therapy for pediatric burns. Burns. 2011 Feb;37(1):61-8. doi: 10.1016/j.burns.2010.07.007. Epub 2010 Aug 7.

    PMID: 20692769BACKGROUND

MeSH Terms

Conditions

Agnosia

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Michael Foley, MD

    Director Department of Obstetrics and Gynecology BUMCP

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Upon enrollment, the patient will be randomized using the REDcap randomization tool.
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: patients will be randomized to either receive virtual reality headsets in the post anesthesia recovery unit (PACU) as an adjunct therapy or undergo routine postoperative management.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Nichole Mahnert, MD, Associate Professor Dept of Obstetrics and Gynecology, MIS Fellowship Co-Director, Endometriosis and Chronic Pelvic Pain Clinic, UofA, BUMCP

Study Record Dates

First Submitted

February 20, 2019

First Posted

February 22, 2019

Study Start

September 1, 2020

Primary Completion

September 19, 2021

Study Completion

March 1, 2023

Last Updated

September 21, 2021

Record last verified: 2021-09

Data Sharing

IPD Sharing
Will not share

Locations